Abbott India Limited
ABBOTINDIA
Classement en actions
#3020
Abbott India Limited is a pharmaceutical enterprise that conducts its... Abbott India Limited is a pharmaceutical enterprise that conducts its operations across India. The company provides an extensive portfolio of medicinal products designed for a broad spectrum of therapeutic areas, including women's health, digestive conditions, metabolic disorders, central nervous system ailments, pain management, premature labor concerns, vitamin supplementation, sleep aids, immunizations, and general consumer health items. Established in 1944, the firm was formerly known as Knoll Pharmaceuticals Limited until it officially adopted the name Abbott India Limited in July 2002. Headquartered in Mumbai, India, it operates as a subsidiary of Abbott Capital India Limited.
Prix de l'action
$284.73
Dernière synchronisation: 2026-10-21
Capitalisation boursière
$6.05B
Changement (1 jour)
-0.41%
Changement (1 an)
-17.16%
Pays
IN
Échange Abbott India Limited (ABBOTINDIA)
Catégorie
Healthcare
Revenus pour Abbott India Limited (ABBOTINDIA)
Revenus en Jun 2026 TTM : $772.99M
Selon les derniers rapports financiers de Abbott India Limited, le chiffre d'affaires actuel de l'entreprise (TTM) est de $772.99M. En 2024, l'entreprise a réalisé un chiffre d'affaires de $701.24M une augmentation par rapport à le chiffre d'affaires de l'année 2023, qui était de $650.61M. Le chiffre d'affaires correspond au revenu total généré par la vente de biens ou de services. Contrairement au bénéfice, aucune dépense n'est déduite.
Historique des revenus pour Abbott India Limited de 2004 à 2026
Revenus à la fin de chaque année
| Année | Revenus | Changez |
|---|---|---|
| 2026 (TTM) | $772.99M | 3.15% |
| 2025 | $749.38M | 6.86% |
| 2024 | $701.24M | 7.78% |
| 2023 | $650.61M | 0.58% |
| 2022 | $646.86M | 9.93% |
| 2021 | $588.44M | 8.35% |
| 2020 | $543.07M | 2.60% |
| 2019 | $529.31M | 4.42% |
| 2018 | $506.91M | 13.64% |
| 2017 | $446.07M | 14.62% |
| 2016 | $389.18M | 8.61% |
| 2015 | $358.32M | 14.89% |
| 2014 | $311.88M | 6.42% |
| 2012 | $293.06M | 7.73% |
| 2011 | $272.03M | 22.82% |
| 2010 | $221.48M | 35.16% |
| 2009 | $163.87M | 22.44% |
| 2008 | $133.84M | -10.95% |
| 2007 | $150.29M | 31.48% |
| 2006 | $114.30M | 17.96% |
| 2005 | $96.90M | 6.51% |
| 2004 | $90.98M | 0.00% |
Revenus d’entreprises similaires ou concurrentes
| Entreprise | Revenus | Différence de revenus | Pays |
|---|---|---|---|
| $79.67B | 10,206.12% |
US
|
|
| $99.34B | 12,750.67% |
US
|
|
| $64.39B | 8,229.42% |
US
|
|
| $66.40B | 8,489.97% |
US
|
|
| $77.52B | 9,928.34% |
CH
|
